Skip to content
lifestyle.tophustler.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Silexion Therapeutics Corp
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 24, 2026
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
May 24, 2026
Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
May 24, 2026
←
Previous Page
1
2